Standard BioTools (LAB) Earnings Date, Estimates & Call Transcripts → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free LAB Stock Alerts $2.36 -0.06 (-2.48%) (As of 04/25/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 14EstimatedActual EPS (Feb. 28) -$0.12 Beat By $0.05 Consensus EPS (Feb. 28) -$0.17 Get Standard BioTools Earnings AlertsEnter your email address below to receive the latest news and earnings results for LAB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LAB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Standard BioTools Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.47) EPSNext Year EPS Consensus Estimate: ($0.32) EPSLAB Earnings Date and InformationStandard BioTools last issued its quarterly earnings results on February 28th, 2024. The reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.17) by $0.05. The company had revenue of $28.19 million for the quarter, compared to the consensus estimate of $28 million. Standard BioTools has generated ($0.95) earnings per share over the last year (($0.95) diluted earnings per share). Earnings for Standard BioTools are expected to grow in the coming year, from ($0.47) to ($0.32) per share. Standard BioTools has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.Read More Standard BioTools Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/14/2024Estimated)------- 2/28/2024Q4 2023($0.17)($0.12)+$0.05$0.01$28.00 million$28.19 million11/7/2023Q3 2023-($0.19)($0.19)($0.11)$23.60 million$25.37 million8/8/2023Q2 2023-($0.18)($0.18)($0.14)$24.20 million$27.67 million5/9/2023Q1 2023-($0.14)($0.14)($0.07)-$25.12 million2/14/2023Q4 2022-($0.21)($0.21)($0.16)-$27.02 million11/8/2022Q3 2022-($0.32)($0.32)($0.27)-$25.65 million Get the Latest News and Ratings for LAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Standard BioTools and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022-($0.39)($0.39)$0.04-$18.78 million5/5/2022Q1 2022-($0.31)($0.31)$0.37-$26.50 million2/17/2022Q4 2021-($0.06)($0.06)--$38.27 million11/8/2021Q3 2021-($0.13)($0.13)($0.08)-$28.50 million8/5/2021Q2 2021($0.15)($0.17)($0.02)($0.11)$30.93 million$31.02 million5/6/2021Q1 2021($0.06)($0.20)($0.14)($0.15)$32.86 million$32.79 million Standard BioTools Earnings - Frequently Asked Questions When is Standard BioTools's earnings date? Standard BioTools has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on LAB's earnings history. Did Standard BioTools beat their earnings estimates last quarter? In the previous quarter, Standard BioTools (NASDAQ:LAB) reported ($0.12) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.17) by $0.05. Learn more on analysts' earnings estimate vs. LAB's actual earnings. How much revenue does Standard BioTools generate each year? Standard BioTools (NASDAQ:LAB) has a recorded annual revenue of $106.34 million. How much profit does Standard BioTools generate each year? Standard BioTools (NASDAQ:LAB) has a recorded net income of -$74.66 million. LAB has generated -$0.95 earnings per share over the last four quarters. What is Standard BioTools's EPS forecast for next year? Standard BioTools's earnings are expected to grow from ($0.47) per share to ($0.32) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CTKB Earnings Results QTRX Earnings Results EYPT Earnings Results PACB Earnings Results ADPT Earnings Results NAUT Earnings Results AKYA Earnings Results HBIO Earnings Results IVAC Earnings Results LUNA Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:LAB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Standard BioTools Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
